Anti-inflammatory role of sympathetic nerves in chronic intestinal inflammation

Straub, R. H.; Grum, F.; Strauch, U.; Capellino, S.; Bataille, F.; Bleich, A.; Faik, W.; Scholmerich, J.; Obermeier, F.
July 2008
Gut;Jul2008, Vol. 57 Issue 7, p911
Academic Journal
Background: Substance P (SP) is a pro-inflammatory neuropeptide in colitis, whereas sympathetic neurotransmitters are anti-inflammatory at high concentrations. Aim and methods: In all layers of the colon, nerve fibre densities of SP+ and sympathetic nerve fibres were investigated (22 Crohn's disease, six diverticulitis, and 22 controls). In addition, the nerve fibre repellent factor semaphorin 3C (SEMA3C) was studied. The functional role of the sympathetic nervous system was tested in dextran sodium sulfate (DSS) and II10-/- colitis. Results: In all layers, Crohn's disease patients demonstrated a loss of sympathetic nerve fibres. Sprouting of SP+ nerve fibres was particularly observed in the mucosa and muscular layer in Crohn's disease. SEMA3C was detected in epithelial cells, and there was a marked increase of SEMA3C-positive crypts in the mucosa of Crohn's disease patients compared to controls. In Crohn's disease, the number of SEMA3C-positive crypts was negatively related to the density of mucosal sympathetic nerve fibres. Sympathectomy reduced acute DSS colitis but increased chronic DSS colitis. Sympathectomy also increased chronic colitis in II10-/- mice. Conclusions: This study demonstrated a loss of sympathetic and an increase of SP+ nerve fibres in Crohn's disease. SEMA3C, a sympathetic nerve repellent factor, is highly expressed in the epithelium of Crohn's disease patients. In chronic experimental colitis, the sympathetic nervous system confers an anti-inflammatory influence. Thus, the loss of sympathetic nerve fibres in the chronic phase of the disease is most probably a pro-inflammatory signal, which might be related to repulsion of these fibres by SEMA3C and other repellents.


Related Articles

  • GI highlights from the literature. McLean, Mairi H. // Gut;May2014, Vol. 63 Issue 5, p857 

    The article presents abstracts on medical topics which includes the role of tuft cells in colonic malignancy, the complexities of host-microbiota interaction and the role of magnetic reasoning (MR) enterography in monitoring and treatment of Crohn's disease.

  • Macrophage-Derived IL-18 Targeting for the Treatment of Crohn's Disease. T. Kanai; K. Uraushihara; T. Totsuka; A. Okazawa; T. Hibi; S. Oshima; T. Miyata; T. Nakamura; M. Watanabe // Current Drug Targets - Inflammation & Allergy;Jun2003, Vol. 2 Issue 2, p131 

    Crohn's disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-a (TNF-a), macrophage infiltrating...

  • Crohn's disease: ethnic variation in CARD15 genotypes. Marsh, S.; McLeod, H.L. // Gut;May2003, Vol. 52 Issue 5, p770 

    Examines the variability in the incidence of Crohn's disease between different world populations. Role of the CARD15 gene in the ethnic variation of the incidence of the disease.

  • Crohn's disease, Crohn disease.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p546 

    An encyclopedia entry for "Crohn's disease" and "Crohn disease," which refer to an inflammatory bowel disease, is presented.

  • Crohn's disease.  // GP: General Practitioner;3/18/2002, p66 

    Focuses on crohn's disease, an inflammatory disorder affecting any part of Gl tract. Clinical features of the disease; Diagnosis of the disease; Pathophysiology of the disease.

  • Changing pattern of paediatric inflammatory bowel disease in northern Stockholm 1990-2001. Hildebrand H; Finkel Y; Grahnquist L; Lindholm J; Ekbom A; Askling J // Gut;Oct2003, Vol. 52 Issue 10, p1432 

    BACKGROUND: An increased incidence of paediatric Crohn's disease was reported recently by our group. AIMS: To assess the incidence and characteristics of inflammatory bowel disease (IBD) in northern Stockholm between 1990 and 2001. METHODS: All records of individuals 0-15 years of age with...

  • Crohn's disease manifesting as an isolated cecal polyp and secondary appendiceal obstruction with histologically normal bowel. Gerada, Jurgen; Borg, Elaine; Cassar, Matthew; DeGaetano, James; LaFerla, Godfrey; Vassallo, Mario // International Journal of Colorectal Disease;Oct2014, Vol. 29 Issue 10, p1307 

    A letter to the editor is presented in response to the article "Crohn's disease manifesting as an isolated cecal polyp and secondary appendiceal obstruction with histologically normal bowel" in the May 21, 2014 issue.

  • Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics. Mandel, Michael; Bálint, Anita; Lovász, Barbara; Gulácsi, László; Strbák, Bálint; Golovics, Petra; Farkas, Klaudia; Kürti, Zsuzsanna; Szilágyi, Blanka; Mohás, Anna; Molnár, Tamás; Lakatos, Péter // European Journal of Health Economics;May2014 Supplement, Vol. 15, p129 

    A correction to the article "Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics" that was published in the May 29, 2014 issue is presented.

  • [sup 99m] Tc-interleukin-2 and [sup 99m] Tc-HMPAO granulocyte scintigraphy in patients with inactive Crohn's disease. Annovazzi, Alessio; Biancone, Livia; Caviglia, Renato; Chianelli, Marco; Capriotti, Gabriela; Mather, Stephen J.; Caprilli, Renzo; Pallone, Francesco; Scopinaro, Francesco; Signore, Alberto // European Journal of Nuclear Medicine & Molecular Imaging;2003, Vol. 30 Issue 3, p374 

    Crohn's disease (CD) is a chronic inflammatory bowel disease that may involve the whole gut. Marked intestinal T cell and macrophage activation is a key feature of the disease. Polymorphonuclear cell infiltration is also observed in the diseased gut, mainly during active inflammation....


Read the Article


Sign out of this library

Other Topics